Discover
AARD
Aardvark Therapeutics, Inc. Common Stock
6.11
1 x 6.16
2 x 6.20
bid
ask
+
0.03
0.49%
12:04 PM
timesize
| Ytd | -53.47% | |
| 1y | -55.56% |
5.81
day range
6.24
3.35
52 week range
17.94
| Open | 6.08 | Prev Close | 6.08 | Low | 5.81 | High | 6.24 | Mkt Cap | 133.06M |
| Vol | 89.91K | Avg Vol | 268.75K | EPS | -3.21 | P/E | -1.89 | Forward P/E | N/A |
| Beta | 3.93 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-07 | 50-d Avg | 4.88 | 200-d Avg | 8.95 | 1yr Est | 0.00 |
| Income Statement | |||
| Operating Expenses | 22.46M | ||
| Research and Development Expense | 16.57M | ||
| Selling, General and Administrative Expense | 5.90M | ||
| Operating Income | -22.46M | ||
| Net Income | -21.59M | ||
| Net Income Common Stock | -21.59M | ||
| Net Income Common Stock (USD) | -21.59M | ||
| Consolidated Income | -21.59M | ||
| Earnings per Basic Share | -0.99 | ||
| Earnings per Basic Share (USD) | -0.99 | ||
| Earnings per Diluted Share | -0.99 | ||
| Earning Before Interest & Taxes (EBIT) | -21.59M | ||
| Earning Before Interest & Taxes (USD) | -21.59M | ||
| Weighted Average Shares | 21.82M | ||
| Weighted Average Shares Diluted | 21.82M | ||
| Balance Sheet | |||
| Cash and Equivalents | 62.44M | ||
| Cash and Equivalents (USD) | 62.44M | ||
| Investments | 28.76M | ||
| Investments Current | 28.76M | ||
| Current Assets | 93.58M | ||
| Property, Plant & Equipment Net | 269.00K | ||
| Total Assets | 98.59M | ||
| Debt Current | 336.00K | ||
| Total Debt | 336.00K | ||
| Current Liabilities | 11.60M | ||
| Total Liabilities | 11.60M | ||
| Accumulated Retained Earnings (Deficit) | -137.51M | ||
| Accumulated Other Comprehensive Income | 14.00K | ||
| Shareholders Equity | 86.99M | ||
| Shareholders Equity (USD) | 86.99M | ||
| Assets Non-Current | 5.01M | ||
| Total Debt (USD) | 336.00K | ||
| Trade and Non-Trade Payables | 4.49M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 97.00K | ||
| Net Cash Flow from Financing | 4.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 15.39M | ||
| Issuance (Purchase) of Equity Shares | 4.00K | ||
| Net Cash Flow from Investing | 34.25M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 34.25M | ||
| Net Cash Flow from Operations | -18.87M | ||
| Share Based Compensation | 2.00M | ||